|
Originally published In Press as doi:10.1074/jbc.M509465200 on November 8, 2005
J. Biol. Chem., Vol. 281, Issue 4, 1868-1875, January 27, 2006
The Physical Properties of the Capsular Polysaccharides from Cryptococcus neoformans Suggest Features for Capsule Construction*
Diane C. McFadden 1,
Magdia De Jesus 2, and
Arturo Casadevall 3
From the
Department of Medicine, Division of Infectious Disease, and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461
The most distinctive feature of the human pathogenic fungus is a polysaccharide capsule that is essential for virulence and is composed primarily of glucuronoxylomannan (GXM) and galactoxylomannan (GalXM). GXM mediates multiple deleterious effects on host immune function, yet relatively little is known about its physical properties. The average mass of Cryptococcus neoformans GXM from four antigenically different strains ranged from 1.7 to 7 x 106 daltons as calculated from Zimm plots of light-scattering data. GalXM was significantly smaller than GXM, with an average mass of 1 x 105 daltons. These molecular masses imply that GalXM is the most numerous polysaccharide in the capsule on a molar basis. The radius of gyration of the capsular polysaccharides ranged between 68 and 208 nm. Viscosity measurements suggest that neither polysaccharide altered fluid dynamics during infection since GXM behaved in solution as a polyelectrolyte and GalXM did not increase solution viscosity. Immunoblot analysis indicated heterogeneity within GXM. In agreement with this, scanning transmission electron microscopy of GXM preparations revealed a tangled network of two different types of molecules. Mass per length measurements from light scattering and scanning transmission electron microscopy were consistent and suggested GXM molecules self-associate. A mechanism for capsule growth is proposed based on the extracellular release and entanglement of GXM molecules.
Received for publication, August 26, 2005
, and in revised form, November 3, 2005.
* This work was supported in part by National Institutes of Health Grants AI33774, AI33142, and HL5984201 (to A. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 A Burroughs Wellcome Fund Fellow of the Life Science Research Foundation.
2 Supported by NCI, National Institutes of Health Training Grant 2T32CA009173-31.
3 To whom correspondence should be addressed: Albert Einstein College of Medicine, 1300 Morris Park Ave., Golding 701, Bronx, NY 10461. Tel.: 718-430-3665; Fax: 718-430-8701; E-mail: casadeva{at}aecom.yu.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Pericolini, E. Gabrielli, E. Cenci, M. De Jesus, F. Bistoni, A. Casadevall, and A. Vecchiarelli
Involvement of Glycoreceptors in Galactoxylomannan-Induced T Cell Death
J. Immunol.,
May 15, 2009;
182(10):
6003 - 6010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Frases, B. Pontes, L. Nimrichter, N. B. Viana, M. L. Rodrigues, and A. Casadevall
Capsule of Cryptococcus neoformans grows by enlargement of polysaccharide molecules
PNAS,
January 27, 2009;
106(4):
1228 - 1233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. De Jesus, A. M. Nicola, M. L. Rodrigues, G. Janbon, and A. Casadevall
Capsular Localization of the Cryptococcus neoformans Polysaccharide Component Galactoxylomannan
Eukaryot. Cell,
January 1, 2009;
8(1):
96 - 103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Klutts and T. L. Doering
Cryptococcal Xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans Plays a Direct Role in the Synthesis of Capsule Polysaccharides
J. Biol. Chem.,
May 23, 2008;
283(21):
14327 - 14334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Rodrigues, M. Alvarez, F. L. Fonseca, and A. Casadevall
Binding of the Wheat Germ Lectin to Cryptococcus neoformans Suggests an Association of Chitinlike Structures with Yeast Budding and Capsular Glucuronoxylomannan
Eukaryot. Cell,
April 1, 2008;
7(4):
602 - 609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Yoneda and T. L. Doering
Regulation of Cryptococcus neoformans Capsule Size Is Mediated at the Polymer Level
Eukaryot. Cell,
March 1, 2008;
7(3):
546 - 549.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Frases, L. Nimrichter, N. B. Viana, A. Nakouzi, and A. Casadevall
Cryptococcus neoformans Capsular Polysaccharide and Exopolysaccharide Fractions Manifest Physical, Chemical, and Antigenic Differences
Eukaryot. Cell,
February 1, 2008;
7(2):
319 - 327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Rodrigues, E. S. Nakayasu, D. L. Oliveira, L. Nimrichter, J. D. Nosanchuk, I. C. Almeida, and A. Casadevall
Extracellular Vesicles Produced by Cryptococcus neoformans Contain Protein Components Associated with Virulence
Eukaryot. Cell,
January 1, 2008;
7(1):
58 - 67.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Nimrichter, S. Frases, L. P. Cinelli, N. B. Viana, A. Nakouzi, L. R. Travassos, A. Casadevall, and M. L. Rodrigues
Self-Aggregation of Cryptococcus neoformans Capsular Glucuronoxylomannan Is Dependent on Divalent Cations
Eukaryot. Cell,
August 1, 2007;
6(8):
1400 - 1410.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Klutts, S. B. Levery, and T. L. Doering
A beta-1,2-Xylosyltransferase from Cryptococcus neoformans Defines a New Family of Glycosyltransferases
J. Biol. Chem.,
June 15, 2007;
282(24):
17890 - 17899.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. De Jesus, E. Hackett, M. Durkin, P. Connolly, A. Casadevall, R. Petraitiene, T. J. Walsh, and L. J. Wheat
Galactoxylomannan Does Not Exhibit Cross-Reactivity in the Platelia Aspergillus Enzyme Immunoassay
Clin. Vaccine Immunol.,
May 1, 2007;
14(5):
624 - 627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. W. Liu, M. J. S. Kelly, E. D. Chow, and H. D. Madhani
Parallel {beta}-Helix Proteins Required for Accurate Capsule Polysaccharide Synthesis and Virulence in the Yeast Cryptococcus neoformans
Eukaryot. Cell,
April 1, 2007;
6(4):
630 - 640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Rodrigues, L. Nimrichter, D. L. Oliveira, S. Frases, K. Miranda, O. Zaragoza, M. Alvarez, A. Nakouzi, M. Feldmesser, and A. Casadevall
Vesicular Polysaccharide Export in Cryptococcus neoformans Is a Eukaryotic Solution to the Problem of Fungal Trans-Cell Wall Transport
Eukaryot. Cell,
January 1, 2007;
6(1):
48 - 59.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Maxson, E. Dadachova, A. Casadevall, and O. Zaragoza
Radial Mass Density, Charge, and Epitope Distribution in the Cryptococcus neoformans Capsule
Eukaryot. Cell,
January 1, 2007;
6(1):
95 - 109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Yoneda and T. L. Doering
A Eukaryotic Capsular Polysaccharide Is Synthesized Intracellularly and Secreted via Exocytosis
Mol. Biol. Cell,
December 1, 2006;
17(12):
5131 - 5140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-A. Pirofski
Of Mice and Men, Revisited: New Insights into an Ancient Molecule from Studies of Complement Activation by Cryptococcus neoformans.
Infect. Immun.,
June 1, 2006;
74(6):
3079 - 3084.
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|